CD8A and neoplasm: We found that the curative efficacy of TVQC, in terms of >70% of mice exhibiting sustained long-term tumor regression, was associated with robust induction of multiple polyfunctional antitumor effector populations, in addition to HPV-antigen-specific CD8 T cells, including a subset of innate NK cells that express the dendritic cell marker CD11c, referred to as NKDCs.